China has not yet integrated HPV vaccination into its national immunization program, though several provinces and cities have launched locally funded or philanthropic initiatives targeting girls aged 12–15. Coverage remains low at 4% by 2022, despite over 85 million doses administered since 2017. The facility‑based strategy relies on strong collaboration between health, education, and finance sectors, with schools central to mobilization. Pilot programs and national action plans aim to scale free HPV vaccination by 2025 and expand nationwide by 2030. Key barriers include high vaccine costs, limited supply, low public awareness, and the absence of approval for a single‑dose schedule.